Distribution of lysosome-associated membrane proteins-1 and-2, and cathepsin D in eosinophilic granular bodies: Possible relationship to cyst development in pilocytic astrocytomas

Journal of International Medical Research

Volumn 38, Issue 4, 2010, Pages 1354-1364

  Tung, J N ^a,b   Tsao, T Y ^b   Tai, C J ^c   Yeh, K T ^d   Cheng, Y W ^a   Jiang, M C ^c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Cathepsin D; Cellular apoptosis susceptibility CSE1L CAS protein; Cyst; Eosinophilic granular bodies; Lysosome associated membrane proteins (LAMP); Matrix metalloproteinase; Pilocytic astrocytomas

Indexed keywords

CATHEPSIN D; CD34 ANTIGEN; CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; GELATINASE A; GELATINASE B; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; CELL INCLUSION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYST FLUID; DISEASE COURSE; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PILOCYTIC ASTROCYTOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR CELL;

EID: 77957744824     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800417     Document Type: Article

References (38)

1. Kleihues P, Cavenee WK (eds): World Health Organization and International Agency for Research on Cancer: Pathology and Genetics of Tumors of the Nervous System. Lyon: IARC Press, 2000; pp 45-51.
2. Takei Y, Mirra SS, Miles ML: Eosinophilic granular cells in oligodendrogliomas: an ultrastructural study. Cancer 1976; 38: 1968-1976.
3. Hitotsumatsu T, Iwaki T, Fukui M, et al: Cytoplasmic inclusions of astrocytic elements of glial tumors: special reference to round granulated body and eosinophilic hyaline droplets. Acta Neuropathol 1994; 88: 501-510.
4. Kalsheker N: α1-Antichymotrypsin. Int J Biochem Cell Biol 1996; 28: 961-964.
5. Gettins PG: Serpin structure, mechanism, and function. Chem Rev 2002; 102: 4751-4804.
6. Vocadlo DJ, Davies GJ, Laine R, et al: Catalysis by hen egg-white lysozyme proceeds via a covalent intermediate. Nature 2001; 412: 835-838.
7. Zuccarello M, Sawaya R, Ray MB: Immunohistochemical demonstration of alpha-1-proteinase inhibitor in brain tumors. Cancer 1987; 60: 804-809.
8. Eskelinen EL, Tanaka Y, Saftig P: At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol 2003; 13: 137-145.
9. Martyn AA, Hong H, Ringuette MJ, et al: Changes in host and parasite-derived cellular and extracellular matrix components in developing cysts of Myxobolus pendula (Myxozoa). J Eukaryot Microbiol 2002; 49: 175-182.
10. Birek P, Wang HM, Brunette DM, et al: Epithelial rests of Malassez in vitro. Phagocytosis of collagen and the possible role of their lysosomal enzymes in collagen degradation. Lab Invest 1980; 43: 61-72.
11. Gerasimov AM, Toporova SM, Furtseva LN, et al: The role of lysosomes in the pathogenesis of unicameral bone cysts. Clin Orthop Relat Res 1991; 266: 53-63.
12. Hazama F, Chue CH, Kataoka H, et al: Pathogenesis of lacuna-like cyst formation and diffuse degeneration of the white matter in the brain of stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol Suppl 1995; 22: S260-S261.
13. Cooper JB: Aspartic proteinases in disease: a structural perspective. Curr Drug Targets 2002; 3: 155-173.
14. Tai CJ, Hsu CH, Shen SC, et al: Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis. J Exp Clin Cancer Res 2010; 29: 110.
15. Jiang MC, Luo SF, Li LT, et al: Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferongamma/ adriamycin-induced apoptosis of Hep G2 hepatoma cells. J Exp Clin Cancer Res 2007; 26: 91-99.
16. Liao CF, Luo SF, Shen TY, et al: CSE1L/CAS, a microtubule-associated protein, inhibits taxol (paclitaxel)-induced apoptosis but enhances cancer cell apoptosis induced by various chemotherapeutic drugs. BMB Rep 2008; 41: 210-216.
17. Liao CF, Luo SF, Tsai CS, et al: CAS enhances chemotherapeutic drug-induced p53 accumulation and apoptosis: use of CAS for high-sensitivity anticancer drug screening. Toxicol Mech Method 2008; 18: 771-776.
18. Tung MC, Tsai CS, Tung JN, et al: Higher prevalence of secretory CSE1L/CAS in sera of patients with metastatic cancer. Cancer Epidemiol Biomarkers Prev 2009; 18: 1570-1577.
19. Tsao TY, Tsai CS, Tung JN, et al: Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon. Mol Cell Biochem 2009; 327: 163-170.
20. Liao CF, Luo SF, Li LT, et al: CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells. J Exp Clin Cancer Res 2008; 27: 15.
21. Stella Tsai CS, Chen HC, Tung JN, et al: Serum cellular apoptosis susceptibility protein is a potential prognostic marker for metastatic colorectal cancer. Am J Pathol 2010; 176: 1619-1628.
22. Gille J, Ehlers EM, Okroi M, et al: Apoptotic chondrocyte death in cell-matrix biocomposites used in autologous chondrocyte transplantation. Ann Anat 2002; 184: 325-332.
23. Roberg K, Kågedal K, Ollinger K: Microinjection of cathepsin D induces caspase-dependent apoptosis in fibroblasts. Am J Pathol 2002; 161: 89-96.
24. Tsai CS, Luo SF, Ning CC, et al: Acetylsalicylic acid regulates MMP-2 activity and inhibits colorectal invasion of murine B16F0 melanoma cells in C57BL/6J mice: effects of prostaglandin F2α. Biomed Pharmacother 2009; 63: 522-527.
25. Ucar E, Borazan A, Semerci E, et al: The effects of interferon α2b on chemically-induced peritoneal fibrosis and on peritoneal tissue MMP-2 and TIMP-2 levels in rats. J Int Med Res 2010; 38: 187-194.
26. Catalyurek H, Oktay G, Guzeloglu M, et al: Insulin-blood cardioplegia decreases matrix metalloproteinase activity in ischaemia-reperfusion injury during coronary artery bypass surgery. J Int Med Res 2008; 36: 551-558.
27. Hou C, Zhang Y: Expression of reversion-inducing cysteine-rich protein with Kazal motifs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus: links to disease activity, damage accrual and matrix metalloproteinase 9 secretion. J Int Med Res 2008; 36: 704-713.
28. Liang HS, Zhong YH, Luo ZJ, et al: Comparative analysis of protein expression in differentiated thyroid tumours: a multicentre study. J Int Med Res 2009; 37: 927-938.
29. Tian X, Cong M, Zhou W, et al: Relationship between protein expression of VEGF-C, MMP-2 and lymph node metastasis in papillary thyroid cancer. J Int Med Res 2008; 36: 699-703.
30. Jung S, Moon KS, Kim ST, et al: Increased expression of intracystic matrix metalloproteinases in brain tumors: relationship to the pathogenesis of brain tumor-associated cysts and peritumoral edema. J Clin Neurosci 2007; 14: 1192-1198.
31. Zattara-Cannoni H, Gambarelli D, Lena G, et al: Are juvenile pilocytic astrocytomas benign tumors? A cytogenetic study in 24 cases. Cancer Genet Cytogenet 1998; 104: 157-160.
32. Gajjar A, Bhargava R, Jenkins JJ, et al: Lowgrade astrocytoma with neuraxis dissemination at diagnosis. J Neurosurg 1995; 83: 67-71.
33. Hu W, Shen F, Chen G, et al: Possible involvement of brain tumour stem cells in the emergence of a fast-growing malignant meningioma after surgical resection and radiotherapy of high-grade astrocytoma: case report and preliminary laboratory investigation. J Int Med Res 2009; 37: 240-246.
34. Dirks PB, Jay V, Becker LE, et al: Development of anaplastic changes in low-grade astrocytomas of childhood. Neurosurgery 1994; 34: 68-78.
35. Parsa CF, Givrad S: Juvenile pilocytic astrocytomas do not undergo spontaneous malignant transformation: grounds for designation as hamartomas. Br J Ophthalmol 2008; 92: 40-46.
36. Nesterenko VS: Proteolytic processes in the small intestine of rats with the intestinal form of acute radiation sickness. Radiobiologiia 1983; 23: 379-381 [in Russian, English abstract].
37. Berezin VA, Lokhanskaia NI, Reva AD, et al: Catalytic properties of catshepsin D from the brains of normal and irradiated animals. Ukr Biokhim Zh 1981; 53: 54-59 [in Russian, English abstract].
38. Sivaparvathi M, Sawaya R, Chintala SK, et al: Expression of cathepsin D during the progression of human gliomas. Neurosci Lett 1996; 208: 171-174.